Article · 2022
Editor
Dr Min Li
Department of Cancer Research, University of Texas, USA
About
As published by the journal they serve.
Dr. Min Li got his PhD from Emory University at Atlanta, Georgia in 2002. Under the supervision of Dr. Richard W. Compans, a world renowned virologist and immunologist, Dr. Li studied the regulation of a retrovirus envelope protein induced membrane fusion and the association with lipid rafts. He then moved on to Baylor College of Medicine at Houston, Texas, and started his career in cancer research as an Assistant Professor in 2004. Dr. Li joined the University of Texas Health Science Center at Houston, Medical School in 2010 as the Director of Cancer Research Program. His research interests include pancreatic cancer and brain tumor pathogenesis, translational research, new therapies and tumor vaccine development. Dr. Lis group is the first one to identify a zinc transporter (ZIP4) as a new molecular target in pancreatic cancer, and has developed a novel therapy to treat this malignancy.
Research interests
Qualifications
MD
Journals they serve
The seats these journals name them in.
- Translational MedicineEditor
Articles we hold
Articles in the journals they serve whose byline carries this name.
Article · 2012
Translational Medicine: Are we Ready for the Prime Time?
Article · 2012
Translational medicine: Opportunities and challenges
This page holds what the journals publish about this profile: no contact details, and nothing gathered from anywhere else. Ask us to correct or remove this profile.
